Bavla
- Located in India, 30km from Ahmedabad
- State of the art R&D centre
- 64 fumehoods
- 200 scientists focused on process development and industrialisation, working in continuous 3 shift, 6 day R&D operations
- Multiple kilo lab and cGMP pilot plant facilities, each with reactors at 50L to 3000L scale
- cGMP pilot plant with full R&D support infrastructure and multipurpose reactors up to 3000L scale. Integral part of R&D centre to ensure seamless process transfer from lab to plant
- Full analytical capability
- Manufacturing facilities
- 800,000 m² site of which 300,000 m² currently developed
- Validated cGMP facilities for pharmaceutical intermediate and API manufacture
- >700 m³ reactor capacity, 250 reactors up to 16000L scale
- FDA inspected 2006
- Specialist reaction capabilities include high pressure autoclaves up to 9000L, dedicated hydrogenation to 5000L at 20 bar, dedicated ozonolysis to 3000L, 20kg/hr ozone, cryogenics to 2500L, asymmetric reactions, organometallics, carboxylation, halogenation, friedel crafts.
- Jet milling, micronising, lyophilisation
- On site waste water treatment and incineration facilities
- Dedicated highly potent (including cytotoxic) API manufacturing facility. 4 segregated reactor trains.
click on the image to enlarge
